STANDAERT, Baudouin

Email Alert RSS Feed

Profile

Full Name
STANDAERT, Baudouin
Email
baudouin.standaert@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 1-15 of 15 (Search time: 0.012 seconds).

Issue DateTitleContributor(s)TypeCat.
12024Measuring the Vaccine Success Index: A Framework for Long-Term Economic Evaluation and Monitoring in the Case of Rotavirus VaccinationSTANDAERT, Baudouin; RAES, Marc; Ethgen, Olivier; Benninghoff, Bernd; Toumi, MondherJournal ContributionA1
22023Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare BudgetKapoor, R; STANDAERT, Baudouin; Pezalla, EJ; Demarteau, N; Sutton, K; Tichy, E; Bungey, G; Arnetorp, S; Bergenheim, K; Darroch-Thompson, D; Meeraus, W; Okumura, LM; Yokota, RTD; Gani, R; Nolan, TJournal ContributionA1
32023Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990STANDAERT, BaudouinJournal ContributionA2
42023The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income CountrySTANDAERT, BaudouinJournal ContributionA1
52022Did we follow the right approach in economic evaluations by discounting health gain?Ethgen, Olivier; STANDAERT, BaudouinConference MaterialC2
62022Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in EuropeSTANDAERT, Baudouin; Benninghoff, BerndJournal ContributionA1
72022Explaining the formation of a plateau in rotavirus vaccine impact on rotavirus hospitalisations in BelgiumSTANDAERT, Baudouin; Strens, Danielle; RAES, Marc; Benninghoff, BerndJournal ContributionA1
82022Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countriesMarijam, Alen; Schuerman, Lode; Izurieta, Patricia; Pereira, Priya; Van Oorschot, Desiree; Mehta, Shailesh; Ota, Martin O. C.; STANDAERT, BaudouinJournal ContributionA1
92022How to design an optimal vaccine launchSTANDAERT, BaudouinJournal ContributionA3
102022Infections and hospital bed-days among aging adults: A five-year retrospective study in a Belgian general hospitalDe Cock, Anne-Marie; Strens, Danielle; Van Osta, Peter; STANDAERT, BaudouinJournal ContributionA1
112022EPH83 an one-year static cross-sectional population model to assess the infection burden across the ageing population: An application to the Flemish CountySTANDAERT, Baudouin; Pham, T. H.; Topachevskyi, O.; Postma, M. J.Journal ContributionM
122022Did we follow the right approach in economic evaluations by discounting health gain?Ethogen, O.; STANDAERT, BaudouinJournal ContributionM
132022Constrained optimization model to estimate best booster allocation strategy to minimize hospital bed-days under a fixed healthcare budgetKapoor, R.; STANDAERT, Baudouin; Nolan, T.; Pezalla, E. J.; Arnetorp, S.; Bergenheim, K.; Bungey, G.; Darroch-Thompson, D.; Gani, R.; Meeraus, W.; Okumura, L.; Sutton, K.; Tichy, E.; Yokota, R.; Demarteau, N.Journal ContributionM
142020Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS)STANDAERT, Baudouin; Strens, Danielle; Pereira, Priya; Benninghoff, Bernd; RAES, MarcJournal ContributionA1
152000Summary measures and statistics in the analysis of quality of life data: An example from an EORTC-NCIC-SAKK locally advanced breast cancer studyCurran, Desmond; Aaronson, Neil; STANDAERT, Baudouin; MOLENBERGHS, Geert; Therasse, Patrick; Ramirez, A.; Koopmanschap, M.; Erder, Haim M.; Piccart, M.Journal ContributionA1